Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variant

  • In US
  • 2021-12-07 12:09:21Z
  • By Reuters

(Reuters) - Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3% effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday.

They said the vaccine's overall efficacy rate against all variants of the coronavirus was 71%, except Omicron, which was not in circulation when the study was underway.

"These are encouraging results given data were obtained in an environment with no ancestral virus circulating. The global COVID-19 pandemic is continuing to show new facets with the current dominance of the Delta variant, upcoming Omicron, and other variants likely to follow," GSK Chief Global Health Officer Thomas Breuer said in a statement.

Last week, infectious disease expert Anthony Fauci said though the focus is on Omicron, 99.9% cases in the United States were due to the Delta variant. "Delta continues to drive cases across the country, especially in those who are unvaccinated."

Medicago will imminently seek regulatory approval for the world's first plant-based COVID-19 vaccine from Health Canada as part of its rolling submission.

The Canadian health regulator in April accepted Medicago's application for a real-time review of the only home-grown COVID-19 vaccine to reach the most advanced level of trials.

Medicago, which uses GSK's adjuvant to boost the efficacy of its vaccine, started the late-stage study in March with over 24,000 participants aged 18 years or above in Canada, United States, United Kingdom, Mexico, Argentina, and Brazil.

The vaccine uses a technology known as virus-like particles, which mimic the structure of the coronavirus, but contain no genetic material from it.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)


More Related News

Fauci: US
Fauci: US 'confident' Omicron will soon peak even as hospitals struggle

Biden chief medical adviser also predicts 'a bit more pain'Cloth or N95? Mask disputes pit employees against bosses Dr Anthony Fauci. Photograph: Kevin...

India's COVID-19 cases rise by 333,533 in last 24 hours - govt
  • US
  • 2022-01-23 05:02:04Z

India reported over 300,000 new COVID-19 infections for the fourth straight day even though the caseload over the last 24 hours was slightly lower than a day...

COVID Infection More Protective Than Vaccines Amid CA Delta Surge
COVID Infection More Protective Than Vaccines Amid CA Delta Surge

Those who were previously sick with COVID-19 had more protection from delta than the vaccinated, California health officials said.

Italy reports 171,263 coronavirus cases on Saturday, 333 deaths
Italy reports 171,263 coronavirus cases on Saturday, 333 deaths
  • US
  • 2022-01-22 16:12:02Z

MILAN (Reuters) -Italy reported 171,263 COVID-19 related cases on Saturday, against 179,106 the day before, the health ministry said, while the number of one...

'Completely full' ICUs as omicron wave stresses hospitals; FDA expands use of remdesivir. Latest COVID-19 updates

In Alabama, cases have soared and ICUs are full. Most of Vermont's hospitals face critical staffing levels, a study found. COVID-19 updates.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: US